Authors:
ANDERSSON BS
MARTINKA S
MCWILLIAMS K
HAI T
MOLLDREM J
BRUTON J
GIAN V
FERNANDEZ H
TARANTOLO S
KASHYAP A
FORMAN SJ
HU W
BLUME K
CAGNONI P
JONES R
CHAMPLIN RE
Citation: Bs. Andersson et al., THERAPY WITH IV BUSULFAN, CYTOXAN (BUCY) AND ALLOGENEIC HEMATOPOIETICSTEM-CELLS (HSC) FOR ADVANCED HEMATOLOGICAL MALIGNANCIES, Bone marrow transplantation, 21, 1998, pp. 333-333
Authors:
KASHYAP A
PARKER P
NADEMANEE A
FUNG H
MOLINA A
BHATIA R
KRISHNAN A
ODONNELL MR
PLANAS I
SNYDER DS
SPIELBERGER R
STEIN A
LEE J
FORMAN SJ
Citation: A. Kashyap et al., ALLOGENEIC (ALLO) AND MATCHED UNRELATED DONOR (MUD) BONE-MARROW TRANSPLANTATION (BMT) IN 46 PATIENTS GREATER-THAN 50 YEARS OF AGE, Blood, 90(10), 1997, pp. 468-468
Authors:
NADEMANEE A
MOLINA A
STEIN A
PLANAS I
FUNG H
DAGIS A
ODONNELL MR
SNYDER DS
PARKER P
SPIELBERGER R
KASHYAP A
BHATIA R
KRISHNAN A
SNIECINSKI K
VORA N
FORMAN SJ
Citation: A. Nademanee et al., HIGH-DOSE THERAPY AND AUTOLOGOUS STEM TRANSPLANTATION (ASCT) AS CONSOLIDATION THERAPY DURING FIRST COMPLETE REMISSION (CR) OR PARTIAL REMISSION (PR) IN PATIENTS WITH UNFAVORABLE PROGNOSIS AND ADVANCED-STAGE HODGKINS-DISEASE (HD), Blood, 90(10), 1997, pp. 495-495
Authors:
ANDERSSON BS
HAI T
MADDEN T
CAGNONI P
JONES R
BRUTON J
MARTINKA S
HOLBERT K
GIRALT S
PRZEPIORKA D
LENNON S
SPILKER B
GIAN V
WINGARD J
TARANTOLO S
KASHYAP A
FORMAN S
CHAMPLIN RE
Citation: Bs. Andersson et al., ALLOGENEIC TRANSPLANTATION IN ADVANCED HEMATOLOGIC MALIGNANCIES AFTER-IV BUSULFAN CYCLOFOSFAMIDE (BUCY), Blood, 90(10), 1997, pp. 1003-1003
Authors:
ODONNELL M
STEIN A
SNYDER DS
NADEMANEE A
PARKER PM
SMITH EP
MOLINA A
KASHYAP A
MARGOLIN K
SOMLO G
FORMAN SJ
Citation: M. Odonnell et al., ALLOGENEIC MARROW TRANSPLANTATION - A CURATIVE OPTION FOR TREATMENT RELATED MYELODYSPLASIA (MDS), Blood, 90(10), 1997, pp. 1008-1008
Authors:
STEIN A
ODONNELL MR
LEE J
BHATIA R
FUNG H
KASHYAP A
KRISHNAN A
NADEMANEE A
MOLINA A
MARGOLIN K
PARKER P
PLANAS I
SPIELBERGER R
SNYDER D
SMITH E
SOMLO G
SLOVAK ML
VORA N
SNIECINSKI I
NILAND J
FORMAN SJ
Citation: A. Stein et al., PHASE-2 STUDY OF INTERLEUKIN-2 (IL-2) FOLLOWING AUTOLOGOUS STEM-CELL TRANSPLANT (ASCT) FOR ADULT PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CR), Blood, 90(10), 1997, pp. 1699-1699
Authors:
SOMLO G
SNYDER D
BROWN A
DAGIS A
NADEMANEE A
ODONNELL M
PARKER P
STEIN A
SMITH E
MOLINA A
SPIELBERGER R
MARGOLIN K
PLANAS I
KASHYAP A
CHOW W
FUNG H
BHATIA R
FORMAN SJ
Citation: G. Somlo et al., TANDEM CYCLE HIGH-DOSE CHEMOTHERAPY (HDCT) OF MELPHALAN (MEL) AND BUSULFAN CYCLOPHOSPHAMIDE (BU/CY) WITH PERIPHERAL-BLOOD PROGENITOR-CELL RESCUE (PBPC) IN MULTIPLE-MYELOMA (MM)/, Blood, 90(10), 1997, pp. 1709-1709
Authors:
FUNG H
NADEMANEE A
KASHYAP A
MOLINA A
ODONNELL M
SNYDER D
PARKER P
STEIN A
PLANAS I
SPIELBERGER R
KRISHNAN A
BHATIA R
MARGOLIN K
SOMLO G
CHOW W
DAGIS A
NILAND J
PEZNER R
FORMAN SJ
Citation: H. Fung et al., EVALUATION OF PROGNOSTIC FACTORS IN PATIENTS (PTS) WITH HODGKIN-DISEASE (HD) IN FIRST RELAPSE (REL) TREATED BY AUTOLOGOUS STEM-CELL TRANSPLANTATION (ASCT) - DURATION OF FIRST REMISSION DOES NOT PREDICT THE TRANSPLANT OUTCOME, Blood, 90(10), 1997, pp. 2637-2637
Authors:
NADEMANEE A
MOLINA A
ODONNELL MR
DAGIS A
SNYDER DS
PARKER P
STEIN A
SMITH E
PLANAS I
KASHYAP A
SPIELBERGER R
FUNG H
WONG KK
SOMLO G
MARGOLIN K
CHOW W
SNIECINSKI I
VORA N
BLUME KG
NILAND J
FORMAN SJ
Citation: A. Nademanee et al., RESULTS OF HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW STEM-CELL TRANSPLANTATION DURING REMISSION IN POOR-RISK INTERMEDIATE-GRADE AND HIGH-GRADE LYMPHOMA - INTERNATIONAL INDEX HIGH AND HIGH-INTERMEDIATE RISK GROUP, Blood, 90(10), 1997, pp. 3844-3852
Citation: J. Calaitges et al., EVERSION CAROTID ENDARTERECTOMY - A SAFE, ADVANTAGEOUS ALTERNATIVE TOCONVENTIONAL CAROTID ENDARTERECTOMY - A PRELIMINARY-REPORT, Vascular surgery, 30(5), 1996, pp. 381-385
Authors:
PARKER P
CHAO NJ
BENEZRA J
SLATKIN N
OPENSHAW H
NILAND JC
LINKER CA
GREFFE BS
KASHYAP A
MOLINA A
NADEMANEE A
ODONNELL MR
PLANAS I
SHEIBANI K
SMITH EP
SNYDER DS
SPIELBERGER R
STEIN AS
STEPAN DE
BLUME KG
FORMAN SJ
Citation: P. Parker et al., POLYMYOSITIS AS A MANIFESTATION OF CHRONIC GRAFT-VERSUS-HOST DISEASE, Medicine, 75(5), 1996, pp. 279-285
Authors:
MODI PI
KASHYAP A
NAIR VD
ROSS GM
FU M
SAVELLI JE
MARCOTTE ER
BARLAS C
MISHRA RK
Citation: Pi. Modi et al., MODULATION OF BRAIN CATECHOLAMINE ABSORBING PROTEINS BY DOPAMINERGIC AGENTS, European journal of pharmacology, 299(1-3), 1996, pp. 213-220
Authors:
PARKER PM
KASHYAP A
SPIELBERGER R
SNIECZINSKI I
CHOW W
FUNG H
MARGOLIN K
MOLINA A
NADEMANEE A
ODONNELL M
PLANAS I
SMITH E
SNYDER DS
SOMLO G
STEIN A
FORMAN SJ
Citation: Pm. Parker et al., IMPROVED CR RATE USING HIGH-DOSE MELPHALAN (HDM) PRE G-CSF-PRIMED DONOR LEUKOCYTE INFUSION (DLI) FOR 2ND ALLOGENEIC BMT - ACUTE GRAFT-VERSUS-HOST DISEASE (AGVHD) PROPHYLAXIS IS NECESSARY FOR PATIENTS AT RISK FOR HYPERACUTE GVHD, Blood, 88(10), 1996, pp. 3805-3805
Authors:
MOLINA A
NADEMANEE A
ODONNELL MR
SNYDER DS
STEIN AS
PARKER PM
SMITH EP
LEE J
PLANAS I
KASHYAP A
SPIELBERGER RT
MARGOLIN K
SOMLO G
KAPOOR N
CHOW W
VORA N
SNIECINSKI I
NILAND J
FORMAN SJ
Citation: A. Molina et al., HIGH-DOSE CHEMO RADIOTHERAPY (HDT) AND G-CSF PRIMED PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION (PBSCT) IN FOLLICULAR LOW-GRADE (FLGL) AND TRANSFORMED (TL) LYMPHOMA/, Blood, 88(10), 1996, pp. 472-472
Authors:
STEIN AS
ODONNELL MR
SLOVAK M
LEE J
KASHYAP A
MOLINA A
NADEMANEE A
PARKER P
PLANAS I
SNYDER DS
SPIELBERGER R
SOMLO G
MARGOLIN K
NILAND J
FORMAN SJ
Citation: As. Stein et al., DO CYTOGENETICS PREDICT OUTCOME OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION (ABMT) FOR ACUTE MYELOGENOUS LEUKEMIA (AML) IN 1ST REMISSION (CR), Blood, 88(10), 1996, pp. 1928-1928
Authors:
MOLINA A
PARKER P
STEIN AS
SPIELBERGER R
NADEMANEE A
SNYDER DS
ODONNELL MR
SMITH EP
MARGOLIN K
DAGIS A
PLANAS I
KASHYAP A
SOMLO G
KAPOOR N
VORA N
NILAND J
FORMAN SJ
Citation: A. Molina et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) IN PATIENTS (PTS) WITH INCURABLE LOW-GRADE LYMPHOPROLIFERATIVE DISORDERS (LGLPD), Blood, 88(10), 1996, pp. 2465-2465
Authors:
NADEMANEE A
MOLINA A
ODONNELL M
SNYDER DS
STEIN A
PARKER P
SMITH E
KASHYAP A
PLANAS I
SPIELBERGER R
FUNG H
SOMLO G
MARGOLIN K
CHOW W
VORA N
DAGIS A
NILAND J
BLUME KG
FORMAN SJ
Citation: A. Nademanee et al., HIGH-DOSE THERAPY AND AUTOLOGOUS BONE-MARROW STEM-CELL TRANSPLANTATION (ABMT) AS CONSOLIDATION THERAPY DURING FIRST CR PR IN PATIENTS WITH POOR-RISK INTERMEDIATE-AND HIGH-GRADE LYMPHOMA/, Blood, 88(10), 1996, pp. 2725-2725
Citation: A. Kashyap et al., ANGIOSARCOMA OF THE SCALP - AN AGGRESSIVE APPROACH TO AN AGGRESSIVE MALIGNANCY - A CASE-REPORT, Vascular surgery, 29(5), 1995, pp. 427-434